显微喉镜CO_2激光喉癌切除术的远期疗效观察  

Long term follow up of laser surgery under micro-endoscopyfor laryngeal carcinoma

作　　者：范献良[1] 张大良[1] 荣宝刚[2] 李新英[1] 

机构地区：[1]山东大学第二医院耳鼻咽喉科,济南250033 [2]山东大学齐鲁医院耳鼻咽喉科

出　　处：《临床耳鼻咽喉科杂志》2005年第18期828-829,共2页Journal of Clinical Otorhinolaryngology

摘　　要：目的:观察显微喉镜下CO2激光手术治疗早期喉癌的远期疗效和生存质量。方法:对20例喉癌患者在显微喉镜下行CO2激光手术。全部病例通过电话、书信和来院复诊等形式随访5～8年。结果:20例患者中,1例术后1年死于局部复发,1例术后2年局部复发行部分喉切除术,1例术后5年出现颈部淋巴结转移行二期颈廓清术,其余17例术后随访5～8年未见复发。5年总治愈率为85%,生存率为95%,局部复发率为10%,局部淋巴结转移率为5%。所有存活者呼吸通畅,发声良好,其中8例完全恢复日常工作,5例经常从事家务劳动,4例有时从事家务劳动。结论:T1及更早期的声门区和声门上区喉癌适合显微喉镜CO2激光手术,其5年生存率及生存质量令人满意,是治疗早期喉癌的较好选择。Objective：To observe the long term curative effect for laryngeal carcinoma treated with CO2 laser under micro-endoscopy. Method：Twenty cases of laryngeal cancer were treated by CO2 laser under micro-endoscopy. All patients were followed up at least 5 （5-8） years by phone, letters or clinical review. Result：During 5 to 8 years following up, one patient died of recurrence 1 year later. Another was operated on with partial laryngectomy due to local recurrence 2 years after laser surgery. The third one was operated with selective neck dissection because of neck metastasis 5 years later. Other 17 cases were alive without recurrent signs. The 5 years total cure rate was 85% and survival rate was 95% ,the 5 years local recurrence rate was 10% and the neck metastasis rate was 5%. All survivals had normal breath and good phonation. Among them 8 resumed their daily works,5 were used to do house works and 4 did them sometimes. Conclusion： T1 and earlier glottic or supraglottic cancers are indications of laser surgery under micro-endoscopy. Its 5 years survival rate as well as live quality were satisfactory and proved the method to he a choice of treatment for earlier laryngeal carcinoma.

关 键 词：喉肿瘤 激光手术 内镜术 远期疗效 

分 类 号：R739.65[医药卫生—肿瘤]